Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.65 -2.37%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Protalix BioTherapeutics Total Assets 2011-2024 | PLX

Annual Total Assets Protalix BioTherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
84.4 M 55.8 M 73.7 M 67.9 M 45.4 M 61.1 M 72.2 M 82.2 M 97.3 M 78.5 M 113 M 78.7 M 51.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
113 M 45.4 M 74 M

Quarterly Total Assets Protalix BioTherapeutics

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
61.6 M 91.5 M 87.6 M 88.4 M 66.6 M 55.8 M 56.7 M 60.6 M 68.4 M 73.7 M 83.5 M 108 M 103 M 67.9 M 67.9 M 67.9 M 67.9 M 45.4 M 45.4 M 45.4 M 45.4 M 61.1 M 61.1 M 61.1 M 61.1 M 72.2 M 72.2 M 72.2 M 72.2 M 82.2 M 82.2 M 82.2 M 82.2 M 97.3 M 97.3 M 97.3 M 97.3 M 78.4 M 78.5 M 78.5 M 78.5 M 113 M 113 M 113 M 113 M 78.7 M 78.7 M 78.7 M 78.7 M 51.8 M 51.8 M 51.8 M 51.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
113 M 45.4 M 75.5 M